Alnylam Pharmaceuticals Other Income and Expenses (Quarterly) Insights

Alnylam Pharmaceuticals, Inc. (ALNY)

327.25 +8.60 (+2.70%) USD | NASDAQ | Mar 04, 15:42

View Other Income and Expenses (Quarterly) for ALNY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Income and Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Income and Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Income and Expenses (Quarterly) Benchmarks

Start Trial